Experimental TB Vaccine Partially Effective: Study
Experimental TB Vaccine Partially Effective: Study
Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients.
Experimental TB Vaccine Partially Effective: Study
Experimental TB Vaccine Partially Effective: Study

Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients.

Tested in patients with the latent form of tuberculosis, the vaccine prevented the development of the active form of infection in 50 percent more individuals compared with unvaccinated patients.

  1. Home
  2. Subjects
  3. mycobacteria

mycobacteria

immunotherapy treatment may cause latent infections of Mycobacterium tuberculosis to flare up in cancer patients
Tuberculosis Can Emerge After Cancer Immunotherapy
Ashley Yeager | Apr 1, 2019
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
Leprosy Researcher Wayne Meyers Dies
Catherine Offord | Oct 2, 2018
An accomplished infectious disease scientist, Meyers spent the 1960s treating and studying the condition in central Africa.
Genome Digest
Jenny Rood | Apr 16, 2015
What researchers are learning as they sequence, map, and decode species’ genomes
Comparing Leprosy Bacteria
Kate Yandell | Mar 27, 2015
Researchers sequence the genome of Mycobacterium lepromatosis, a recently discovered sister species to the primary leprosy-causing bacterium.
Bacterial Gene Transfer Gets Sexier
Kate Yandell | Jul 9, 2013
Mycobacterium smegmatis can donate larger portions of its genome to other bacteria than previously thought, approaching the level of gene shuffling seen in sexual reproduction.
Beating Drug-Resistant TB
Ruth Williams | Sep 19, 2012
Reinvestigating a natural antibiotic compound reveals its potential as a tuberculosis drug.
Swimming with the mycobacteria
Cathryn Delude | Jun 5, 2005
The patients were working out in a hospital's warm therapeutic pool in Boulder, Colorado, when Mark Hernandez walked in and dipped sterile bottles in the water.